by Sue Robbins | Jul 25, 2019 | Headache Drugs, Migraine
Nine drug companies have received approval for the first generic versions of Lyrica (pregabalin), the U.S. Food and Drug Administration announced. Read more here.
by Sue Robbins | Jul 25, 2019 | Migraine
Read more here.
by Sue Robbins | Jul 24, 2019 | Migraine
Read more here.
by Sue Robbins | Jul 23, 2019 | Migraine
Migraine patients fared as well when managed for a year by telemedicine as did patients managed by a 12-month series of routine office visits in a single-center, randomized trial with 40 patients Read more here.
by Sue Robbins | Jul 22, 2019 | Migraine
The level of exposure to white light is associated with acute risk of headache onset in patients with episodic migraine, according to research presented at the annual meeting of the American Headache Society. The data raise the question of whether modifying light...
